Respiratory Institute, Cleveland Clinic, Cleveland, OH
Medical ICU Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
Cleve Clin J Med. 2022 Jul 1;89(7):363-367. doi: 10.3949/ccjm.89a.21085.
Critically ill patients are at an increased risk for developing stress ulcers of the mucosa of the upper gastrointestinal (GI) tract. Bleeding from stress ulcers was previously associated with a longer stay in the intensive care unit and an increased risk of death. Thus, most patients admitted to the intensive care unit receive stress ulcer prophylaxis. However, there is a growing concern that acid-suppression drugs may be associated with increased frequency of nosocomial pneumonia and infection. In this article, the authors address controversies regarding stress ulcer prophylaxis in critically ill patients and provide guidance for its appropriate use in this setting.
危重症患者发生上消化道(GI)黏膜应激性溃疡的风险增加。应激性溃疡出血以前与 ICU 住院时间延长和死亡风险增加相关。因此,大多数入住 ICU 的患者接受应激性溃疡预防治疗。然而,人们越来越担心抑酸药物可能与医院获得性肺炎和感染的发生率增加有关。本文作者讨论了有关危重症患者应激性溃疡预防的争议,并为其在该环境中的合理使用提供了指导。